Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03734822 · ClinicalTrials.gov registry record · NA
Comparative Analysis of CO2 Monitoring Methods in Patients With CF Undergoing General Anesthesia
A NA study, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
NCT03734822 is a NA study that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 47 participants.
The verdict
NCT03734822, a NA study, has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
Study Summary
Four methods are routinely used to monitor CO2 in patients. End tidal CO2 (EtCO2) is monitored through the endotracheal tube during general anesthesia. CO2 is also monitored in other healthcare settings transcutaneously (TCO2), via finger stick capillary CO2 (CapCO2), and arterial blood gas (ABG). The purpose of this study is to perform all four measurements simultaneously during general anesthesia to identify which measure provides the most accurate data with the least amount of patient risk.
Interventions
- OTHER End tidal CO2 (EtCO2)
- DEVICE Transcutaneous CO2 (TCO2)
- DIAGNOSTIC_TEST Capillary CO2 (CapCO2)
- DIAGNOSTIC_TEST Arterial blood gas (ABG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2016-03-10 |
| Est. Completion | 2017-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03734822
The ClinicalTrials.gov registry entry for NCT03734822 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which End tidal CO2 (EtCO2) is the first listed.
NCT03734822 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03734822 about?
NCT03734822 is a clinical study titled "Comparative Analysis of CO2 Monitoring Methods in Patients With CF Undergoing General Anesthesia". Four methods are routinely used to monitor CO2 in patients. End tidal CO2 (EtCO2) is monitored through the endotracheal tube during general anesthesia. CO2 is also monitored in other healthcare settings transcutaneously (TCO2), via finger stick capillary CO2 (CapCO2), and arterial blood gas (ABG). T...
What is the current status of trial NCT03734822?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2016-03-10. Estimated completion is 2017-12-20.
What interventions are being tested in trial NCT03734822?
The interventions under investigation include: End tidal CO2 (EtCO2) (OTHER), Transcutaneous CO2 (TCO2) (DEVICE), Capillary CO2 (CapCO2) (DIAGNOSTIC_TEST), Arterial blood gas (ABG) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03734822?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.